{"meta":{"query_hash":"ffe8a0880ff0","filters":{"venue":"Current Radiopharmaceuticals"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ffe8a0880ff0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Radiopharmaceuticals"},"results":[{"id":"W2010039427","doi":"10.2174/1874471007666140711115620","title":"Microwave-assisted Radiosynthesis of the Hypoxia Marker 1-&amp;#945;-D-(5- Deoxy-5-[&lt;sup&gt;18&lt;/sup&gt;F]fluoroarabinofuranosyl)-2-nitroimidazole ([&lt;sup&gt;18&lt;/sup&gt;F]FAZA)","year":2014,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Health Canada","keywords":"Radiosynthesis; Chemistry; Reagent; Nitroimidazole; Radiochemistry; High-performance liquid chromatography; Cartridge; Nuclear chemistry; Thermal decomposition; Chromatography; Nuclear medicine; Organic chemistry; Materials science; Positron emission tomography","score_opus":0.03485171306212833,"score_gpt":0.300961287242398,"score_spread":0.2661095741802697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010039427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9024112,0.0036821158,0.084581845,0.00011763419,0.00007032382,0.00023780852,0.00073542696,0.00077991665,0.0073836762],"genre_scores_gemma":[0.92288274,0.0017606502,0.06636954,0.000061470724,0.000036177396,0.00020724341,0.00084422884,0.00014005737,0.007697901],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989784,0.000018508737,0.0000056824174,0.000039407627,0.000019843614,0.000018735007],"domain_scores_gemma":[0.9998965,0.000026478803,0.000034851968,0.00001921803,0.000013977415,0.000008969703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002990108,0.0004175384,0.00017004223,0.000269492,0.00015208493,0.00017339115,0.0004013624,0.00023854559,0.0018853453],"category_scores_gemma":[0.00022807201,0.00016181219,0.00022978018,0.00023345371,0.0002461838,0.00016198416,0.00018547334,0.00034184632,0.0007783155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010182477,0.00001052702,0.00009423352,0.00005359564,0.000005646155,0.000026921685,0.000018484589,0.00013897583,0.99545926,0.000111074354,0.00008151242,0.0038978818],"study_design_scores_gemma":[0.0000106928155,0.00019107279,0.0009756764,0.0000029994394,0.000013718513,0.00016900705,0.000005469612,0.00047163377,0.9949694,0.000013324821,0.003172803,0.000004190711],"about_ca_topic_score_codex":0.0006572511,"about_ca_topic_score_gemma":0.0011294682,"teacher_disagreement_score":0.0018853453,"about_ca_system_score_codex":0.00027348794,"about_ca_system_score_gemma":0.0002167531,"threshold_uncertainty_score":0.006307125},"labels":[],"label_agreement":null},{"id":"W2029410023","doi":"10.2174/1874471011104020090","title":"Radiotracers Based on Technetium-94m","year":2011,"lang":"en","type":"review","venue":"Current Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Positron emission tomography; Molecular imaging; Pet imaging; Technetium; Solvent extraction; Chemistry; Radiochemistry; Technetium-99m; Nuclear medicine; Medical physics; Nanotechnology; Materials science; Extraction (chemistry); Medicine; Nuclear chemistry; Scintigraphy; Organic chemistry; In vivo","score_opus":0.26203448382392924,"score_gpt":0.49481664036470324,"score_spread":0.232782156540774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029410023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010343575,0.9581506,0.0128838355,0.00037657216,0.00037040404,0.00009689392,0.00011987908,0.00016482495,0.017493388],"genre_scores_gemma":[0.067116395,0.8996113,0.016156374,0.00073062297,0.00034239056,0.00019263214,0.00034219696,0.000042704778,0.015465475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998491,0.00002154992,0.000009895239,0.000032337182,0.000066533124,0.000020575435],"domain_scores_gemma":[0.99995077,0.000017536066,0.00001141454,0.0000029811297,0.0000116517995,0.000005601097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003142722,0.0007363282,0.0008428491,0.001161587,0.00017579636,0.00053528463,0.0007158615,0.0007723899,0.001728857],"category_scores_gemma":[0.00024530586,0.00026921442,0.0003197238,0.0010201397,0.00031272342,0.00059076224,0.00039577472,0.00071021164,0.0025045862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024549934,0.00011623628,0.000469777,0.00811796,0.000108170374,0.0013219083,0.00009196687,0.0010086294,0.3369144,0.012672482,0.008327799,0.6306052],"study_design_scores_gemma":[0.000035796747,0.00043144028,0.0009766353,0.0004397446,0.00011873357,0.006639764,0.000045596367,0.00048983796,0.23639002,0.0013143951,0.7530717,0.0000463842],"about_ca_topic_score_codex":0.0004849258,"about_ca_topic_score_gemma":0.00053788023,"teacher_disagreement_score":0.001728857,"about_ca_system_score_codex":0.000523737,"about_ca_system_score_gemma":0.00038987547,"threshold_uncertainty_score":0.0057836175},"labels":[],"label_agreement":null},{"id":"W2106336755","doi":"10.2174/1874471008666150312164255","title":"Evaluation of &lt;sup&gt;177&lt;/sup&gt;Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy","year":2015,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Dosimetry; Osteosarcoma; Palliative care; Bone metastasis; Bone cancer; Metastasis; Cancer; Nuclear medicine; Internal medicine; Cancer research","score_opus":0.11102454370383812,"score_gpt":0.40013503990600524,"score_spread":0.2891104962021671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106336755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814296,0.0005065846,0.00090811023,0.000029507264,0.000004439082,0.000028317574,0.000083032726,0.000017504348,0.00027948126],"genre_scores_gemma":[0.9981097,0.00036263664,0.0008351591,0.000021225254,0.0000063741986,0.000022382019,0.00029072928,0.000012618146,0.0003391154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999051,0.000029300112,0.000005019054,0.000024339388,0.000018669025,0.000017519136],"domain_scores_gemma":[0.9998784,0.000039077826,0.000029546649,0.000013994861,0.000016215059,0.000022689359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022901947,0.00019298542,0.0003870988,0.00016424198,0.00015861579,0.00019140083,0.00016857656,0.0002937126,0.0005668943],"category_scores_gemma":[0.00028141253,0.00013113704,0.00015208712,0.00017897556,0.00035453335,0.00020156516,0.00012335363,0.00027735028,0.00015802131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037403323,0.0008376025,0.004907547,0.00020364352,0.000044306908,0.00058745424,0.00021398457,0.0010327151,0.9793408,0.00016551808,0.00018318943,0.008742873],"study_design_scores_gemma":[0.00037854764,0.047769904,0.02270895,0.000007980335,0.00023194018,0.0047064223,0.00025982907,0.0052647768,0.91253495,0.00014162464,0.0059729633,0.00002214201],"about_ca_topic_score_codex":0.00050354097,"about_ca_topic_score_gemma":0.0005249552,"teacher_disagreement_score":0.0005668943,"about_ca_system_score_codex":0.00027386524,"about_ca_system_score_gemma":0.00016321223,"threshold_uncertainty_score":0.00198704},"labels":[],"label_agreement":null},{"id":"W2107252164","doi":"10.2174/1874471011205010038","title":"Biochemistry and Biology of 2'-Fluoro-2'-Deoxythymidine (FT), A Putative Highly Selective Substrate for Thymidine Kinase Type 2 (TK2)","year":2011,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Institute","keywords":"Thymidine; Thymidine kinase; Nucleoside; Nucleoside transporter; Biodistribution; Kinase; Chemistry; Phosphorylation; Cytosol; Biochemistry; Molecular biology; Transporter; Biology; DNA; In vitro; Gene; Herpes simplex virus; Enzyme; Virology","score_opus":0.14940100574545567,"score_gpt":0.4355562750792231,"score_spread":0.28615526933376745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107252164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9067904,0.05872866,0.01900877,0.0005382195,0.00022217262,0.000039549122,0.0012525603,0.00022267555,0.013197011],"genre_scores_gemma":[0.97721386,0.010726858,0.0041449675,0.000076276956,0.00003403245,0.000013241783,0.0010743134,0.000020769801,0.006695788],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994504,0.0000065229156,0.0000024538365,0.000020010035,0.00001449393,0.000011323205],"domain_scores_gemma":[0.999964,0.0000041715057,0.000006978858,0.000003395455,0.000011919765,0.000009528713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011764718,0.00026195197,0.00016472158,0.00012377829,0.00017399814,0.0004975937,0.00018368682,0.00034434497,0.00047057515],"category_scores_gemma":[0.00009730553,0.000117484735,0.00016660464,0.00013216013,0.00014727327,0.0003040591,0.00009405392,0.0002468666,0.00040462363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076355704,0.000013491536,0.000447832,0.00008264521,0.000004979032,0.000081507904,0.000026667858,0.00040614005,0.99249774,0.00093106704,0.00012854802,0.0053030592],"study_design_scores_gemma":[0.000009323691,0.00018522254,0.008229566,0.000010768493,0.000015087789,0.00093263964,0.000037723414,0.0020403191,0.96842825,0.00037783702,0.019717883,0.00001526992],"about_ca_topic_score_codex":0.0026478057,"about_ca_topic_score_gemma":0.0016805433,"teacher_disagreement_score":0.0026478057,"about_ca_system_score_codex":0.0009419889,"about_ca_system_score_gemma":0.00030497566,"threshold_uncertainty_score":0.006834686},"labels":[],"label_agreement":null},{"id":"W2152960820","doi":"10.2174/1874471011104010044","title":"PET Measurements of cAMP-Mediated Phosphodiesterase-4 with (R)-[11C]Rolipram","year":2011,"lang":"en","type":"review","venue":"Current Radiopharmaceuticals","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; University of Ottawa","keywords":"Rolipram; Phosphodiesterase; Chemistry; Pharmacology; Internal medicine; Medicine; Enzyme; Biochemistry","score_opus":0.14564855670816668,"score_gpt":0.3878914254414068,"score_spread":0.24224286873324014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152960820","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.897927,0.011577174,0.07678131,0.0005490862,0.00011140148,0.0003340171,0.001497035,0.00062424724,0.010598822],"genre_scores_gemma":[0.908429,0.0077713607,0.07104921,0.0005609824,0.00011953046,0.00092537166,0.0019051147,0.00017987011,0.009059575],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995247,0.00022021176,0.000017497447,0.00009326087,0.000060243266,0.000084041196],"domain_scores_gemma":[0.99978846,0.00007268448,0.000047968486,0.000026199225,0.000041622876,0.000023187995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070910016,0.0007145978,0.00060159795,0.0004888482,0.0002762743,0.0006418025,0.0007639887,0.0013232977,0.0018474674],"category_scores_gemma":[0.0007749245,0.00049163116,0.0004570257,0.00085052155,0.00046454236,0.00057579565,0.00032574718,0.0010533811,0.00063419313],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013155245,0.00011284854,0.0015600926,0.0002464846,0.0000776647,0.00045885606,0.00011770931,0.000993654,0.9870068,0.0002823207,0.00040096653,0.0074270307],"study_design_scores_gemma":[0.0001632637,0.002257418,0.014541539,0.00004789984,0.00033089748,0.003006719,0.00014844885,0.013800727,0.95870674,0.0002913892,0.0066453405,0.00005973593],"about_ca_topic_score_codex":0.0010465238,"about_ca_topic_score_gemma":0.0010096999,"teacher_disagreement_score":0.0018474674,"about_ca_system_score_codex":0.0005083966,"about_ca_system_score_gemma":0.00030655303,"threshold_uncertainty_score":0.0061804056},"labels":[],"label_agreement":null},{"id":"W2620069305","doi":"10.2174/1874471010666170313120540","title":"β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors","year":2017,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Energy","funders":"","keywords":"Biodistribution; Chemistry; Synthon; Tumor hypoxia; Radiochemistry; Nuclear chemistry; Stereochemistry; Medicine; Biochemistry; In vitro; Radiology","score_opus":0.031945014946543046,"score_gpt":0.3352385989887168,"score_spread":0.3032935840421737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620069305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586805,0.0032003482,0.028034253,0.00014449559,0.000037397094,0.00031399372,0.0017574248,0.00038896714,0.007442615],"genre_scores_gemma":[0.9580697,0.0027360094,0.030419474,0.00006731687,0.000018224146,0.00019513885,0.0022935597,0.000087390756,0.0061131413],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999492,0.000007633136,0.0000043444293,0.000012565702,0.000012897789,0.000013470518],"domain_scores_gemma":[0.9999304,0.0000130941835,0.000016906391,0.000008954921,0.000016101114,0.000014576389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014558424,0.00033877528,0.00011920043,0.00016684373,0.00012512377,0.00014849924,0.00019852104,0.00029424904,0.0010137863],"category_scores_gemma":[0.00011152636,0.00009587559,0.00013676952,0.00016800496,0.00015636566,0.00017987855,0.00007439671,0.0003285451,0.0006817349],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080621416,0.000016419412,0.00008630373,0.000027410466,0.0000030378217,0.000033900065,0.00000844638,0.00024649198,0.9974643,0.000082097526,0.000036424062,0.0019145558],"study_design_scores_gemma":[0.000007572738,0.00015798701,0.0005251432,0.0000018636788,0.000005564671,0.00009480826,0.0000034895395,0.00024238876,0.99626935,0.000012546328,0.002676915,0.0000022787108],"about_ca_topic_score_codex":0.0010275372,"about_ca_topic_score_gemma":0.00096029387,"teacher_disagreement_score":0.0010275372,"about_ca_system_score_codex":0.00021558323,"about_ca_system_score_gemma":0.00021760252,"threshold_uncertainty_score":0.0033914447},"labels":[],"label_agreement":null},{"id":"W2896597653","doi":"10.2174/1874471011666181019105947","title":"Synthesis of [18F]FAZA Using Nosyl and Iodo Precursors for Nucleophilic Radiofluorination","year":2018,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Fluorine in Organic Chemistry","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Energy","funders":"","keywords":"Nucleophile; Chemistry; Combinatorial chemistry; Organic chemistry; Catalysis","score_opus":0.20523371665351525,"score_gpt":0.5001881227053421,"score_spread":0.2949544060518268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896597653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7967688,0.008795529,0.17402975,0.00037464203,0.00032442994,0.0008311936,0.0017359316,0.0010103573,0.016129326],"genre_scores_gemma":[0.81725544,0.0051431837,0.16343233,0.00016664679,0.00005653608,0.00048347365,0.0020190575,0.0001977378,0.011245709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998368,0.000031384,0.000016081314,0.00004848968,0.00003996092,0.000027310924],"domain_scores_gemma":[0.9997451,0.00004010607,0.00007073045,0.000046344598,0.00006239738,0.000035402936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031897664,0.00061860494,0.00028259284,0.00023467085,0.00018821187,0.00022702865,0.00041137976,0.00054947054,0.0019841488],"category_scores_gemma":[0.00037518598,0.0002663996,0.00026413333,0.00019245583,0.00025110441,0.00031777378,0.0002181029,0.00062426913,0.0017823889],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068813366,0.000010244898,0.000058165806,0.00007666969,0.000004305317,0.000111422225,0.000025140907,0.000121815516,0.99650013,0.00024433687,0.00005024143,0.0027288327],"study_design_scores_gemma":[0.000020574693,0.00015949743,0.00028911847,0.0000083468485,0.000011594155,0.0003360175,0.000009516587,0.00023326091,0.98564065,0.000040177365,0.013241693,0.0000095383475],"about_ca_topic_score_codex":0.0005351811,"about_ca_topic_score_gemma":0.0011263539,"teacher_disagreement_score":0.0019841488,"about_ca_system_score_codex":0.00030536114,"about_ca_system_score_gemma":0.000495187,"threshold_uncertainty_score":0.006637633},"labels":[],"label_agreement":null},{"id":"W3119167128","doi":"10.2174/1874471014999210111201630","title":"Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119.","year":2021,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TRIUMF; Simon Fraser University","funders":"National Cancer Institute; National Institute on Aging; Natural Sciences and Engineering Research Council of Canada","keywords":"Antimony; Mercury (programming language); Radionuclide; Auger electron spectroscopy; Radiochemistry; Materials science; Auger; Chemistry; Nuclear physics; Metallurgy; Atomic physics; Physics; Computer science","score_opus":0.0672970725856563,"score_gpt":0.40996170514180147,"score_spread":0.34266463255614515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119167128","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.123214446,0.6557007,0.12061021,0.0024124684,0.0015838987,0.0006019339,0.00061954174,0.00090141414,0.09435533],"genre_scores_gemma":[0.4851928,0.2983751,0.13403663,0.0020272941,0.00038558702,0.0007250142,0.001337622,0.00027253298,0.077647425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99983764,0.000028715733,0.000007982083,0.000034764136,0.00007139692,0.000019499685],"domain_scores_gemma":[0.9999571,0.000009119774,0.00001374645,0.0000042201978,0.00000799371,0.000007827907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047333876,0.0005033507,0.00031165968,0.0008786961,0.00026747718,0.00037720634,0.00048463125,0.00088766037,0.0022227364],"category_scores_gemma":[0.00023916842,0.0002022908,0.00027818742,0.00069027767,0.00031763685,0.0005654088,0.00050710654,0.0007873054,0.0013410884],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024710098,0.00010225639,0.00085516064,0.0020883793,0.00006335925,0.00079687196,0.00021445463,0.00056509464,0.8025808,0.025164107,0.007488476,0.15983394],"study_design_scores_gemma":[0.00004270799,0.00054669613,0.0013521585,0.00014976745,0.000059970516,0.002214072,0.00005729116,0.000544395,0.6694,0.001507022,0.32409495,0.000030967185],"about_ca_topic_score_codex":0.00048748477,"about_ca_topic_score_gemma":0.0011921949,"teacher_disagreement_score":0.0022227364,"about_ca_system_score_codex":0.0006683315,"about_ca_system_score_gemma":0.00036154556,"threshold_uncertainty_score":0.0074357986},"labels":[],"label_agreement":null},{"id":"W3122176437","doi":"10.2174/1874471014999210128183231","title":"Head and Neck Cancer Treatments through Chemotherapy to Magnetic Systems: Perspectives and Challenges","year":2021,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Biological Research and Disease Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Universidade Federal do Rio de Janeiro; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Head and neck cancer; Head and neck; Medicine; Chemotherapy; Cancer; Oncology; Internal medicine; Surgery","score_opus":0.106707229216191,"score_gpt":0.43000119695401523,"score_spread":0.32329396773782426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122176437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011594936,0.9847987,0.00025594156,0.009687696,0.0004881501,0.0000079049805,0.00010701433,0.000013277434,0.0034818244],"genre_scores_gemma":[0.011022424,0.9849975,0.0004920616,0.0019381576,0.00082691753,0.000015142274,0.00009450754,0.0000047184417,0.0006085968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824846,0.000575617,0.00021394077,0.00017635939,0.00068510626,0.000100486744],"domain_scores_gemma":[0.9912948,0.005191999,0.0009947973,0.00016629203,0.002150636,0.0002015852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029267138,0.00046838835,0.0011239932,0.006520086,0.0006005072,0.0035425692,0.0007582609,0.0011951494,0.0055685067],"category_scores_gemma":[0.0069425693,0.00022437423,0.0008645044,0.011434735,0.0012487366,0.004010137,0.00080356316,0.0010796274,0.0010720815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008913791,0.00006776626,0.003515614,0.07069492,0.00032982553,0.00036533194,0.00080649945,0.00042668392,0.0017361263,0.015676033,0.05069766,0.85559434],"study_design_scores_gemma":[0.000017717008,0.00017805368,0.013548317,0.045691047,0.0007518714,0.0017430078,0.0038364932,0.0003959825,0.0010146465,0.0159548,0.91679376,0.000074256954],"about_ca_topic_score_codex":0.0035582073,"about_ca_topic_score_gemma":0.0073172688,"teacher_disagreement_score":0.006520086,"about_ca_system_score_codex":0.0023237616,"about_ca_system_score_gemma":0.0050378293,"threshold_uncertainty_score":0.018628478},"labels":[],"label_agreement":null},{"id":"W3198054476","doi":"10.2174/1874471014666210810100435","title":"Toxicity and Tolerability of 177Lu-DOTA-TATE PRRT with a Modified AdministeredActivity Protocol in NETs of Variable Origin – A Phase 2 RegistryStudy","year":2021,"lang":"en","type":"article","venue":"Current Radiopharmaceuticals","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Cancer Care Ontario","keywords":"Tolerability; Protocol (science); Pharmacology; Medicine; Toxicity; Internal medicine; Pathology; Alternative medicine; Adverse effect","score_opus":0.1195016388608112,"score_gpt":0.48263165212439724,"score_spread":0.36313001326358607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198054476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679285,0.00025675292,0.0007708069,0.000033450135,0.00001188659,0.0011886562,0.0005378704,0.000036817022,0.00037100454],"genre_scores_gemma":[0.9916073,0.00040384982,0.0014925881,0.0001494077,0.000034162815,0.0030442856,0.0027162766,0.000024065188,0.00052816333],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99693596,0.0021518774,0.00020223415,0.00024727918,0.0002726894,0.00018988794],"domain_scores_gemma":[0.9981396,0.0003081654,0.000701945,0.00046224572,0.00015443585,0.000233615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063372036,0.000702937,0.0010231858,0.00029791612,0.00036558896,0.0007349086,0.0007441963,0.0007581334,0.0013317917],"category_scores_gemma":[0.0021659837,0.00027833172,0.00087909977,0.0005865213,0.00070126896,0.0005326546,0.0003599893,0.0012916581,0.0003869853],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4471014,0.13007744,0.15941654,0.0012142485,0.0029533957,0.00088571204,0.0011037828,0.009905996,0.09037081,0.00038054894,0.005166542,0.15142359],"study_design_scores_gemma":[0.094664946,0.74885195,0.13237451,0.00005061749,0.0007822979,0.0014008825,0.00019943877,0.0034658406,0.013770768,0.00010785976,0.0042777727,0.000053214797],"about_ca_topic_score_codex":0.00076864916,"about_ca_topic_score_gemma":0.00088440446,"teacher_disagreement_score":0.0063372036,"about_ca_system_score_codex":0.00101499,"about_ca_system_score_gemma":0.001108057,"threshold_uncertainty_score":0.033514798},"labels":[],"label_agreement":null}]}